MedTrace Logo

Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula

NCT01315080 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2011-03-15

No results posted yet for this study

Summary

The investigators recently proposed a new hypothesis on the pathogenesis of mammillary fistulae (MF) suggesting that occlusion of hair follicles by keratinous plugging may relevantly contribute to the development of MF. The investigators believe that the pathogenesis of MF mimics the behaviour of hidradenitis suppurative, as both clinical entities manifest themselves as a chronic, suppurative and recurrent inflammatory process. This new proposal has led to the present suggestion of a therapeutic alternative for MF.

Conditions

  • Mammillary Fistula

Sponsors & Collaborators

  • Hospital Universitario Virgen de la Arrixaca

    lead OTHER

Principal Investigators

  • Juan D Berna, MD PhD · Virgen de la Arrixaca University Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-03-31
Completion
2012-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01315080 on ClinicalTrials.gov